BET Bromodomain Targeting by NSAIDs : Structural, Biophysical, and Computational Insights
Proteins: Structure, Function, and Bioinformatics · 2026-12 · 94 (12) · 1965-1989
DOI: 10.1002/prot.70154 ↗At a glance
Journal article in Proteins: Structure, Function, and Bioinformatics, published online on 2026-07-15. Written by Ashok Sridhar and 5 co-authors. Institution: Department of Biophysics, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India. Major MEDLINE topics: Anti-Inflammatory Agents, Non-Steroidal, Sulfonamides, Transcription Factors, Nuclear Proteins. 46 references. Funded by: Indian Council of Medical Research, Department of Science and Technology, Ministry of Science and Technology, India, Department of IT, BT & ST.
Abstract (original language)
The bromodomain and extra‐terminal (BET) family of proteins, which regulate chromatin function, is an established potential drug target for treating major diseases such as cancer and inflammatory conditions. There is significant research focused on developing new BET inhibitors with innovative molecular structures to target and modulate the epigenetic mechanisms underlying major diseases, including cancer. Herein, we present the crystal structures of the second bromodomain (BD2) of hBRD2 in complex with the FDA‐approved drugs, mefenamic acid (ID8) and nimesulide (NIM), and that of the first bromodomain (BD1) of hBRD4 in complex with nimesulide (NIM). Quantitative binding assays by surface plasmon resonance (SPR) confirmed the substantial binding of these drug molecules to the hBRD2 and hBRD4 bromodomains. Using these crystal structures, a series of ID8 and NIM derivatives with improved affinity relative to the parent compounds was designed and evaluated using SeeSAR (BioSolveIT GmbH). Moreover, molecular dynamics simulations were performed on the selected derivatives of ID8 and NIM against these bromodomains and confirmed the stability of these derivatives' binding throughout the simulations. We propose that the derivatives of the aforementioned parent molecules may be potential inhibitors of the function of hBRD2 and hBRD4.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Department of Biophysics, National Institute of Mental Health and Neurosciences (NIMHANS), Bengaluru, India.
- Institute of Bioinformatics and Applied Biotechnology (IBAB), Bengaluru, India.
ORCID profiles: Saravanamuthu Thiyagarajan
Funding
- Indian Council of Medical Research
- Department of Science and Technology, Ministry of Science and Technology, India
- Department of IT, BT & ST
- Government of Karnataka to IBAB
Cite
APA
Sridhar, A., Kandhasami, N., Mathur, S., Krishnappa, G., Thiyagarajan, S., & Padmanabhan, B. (2026). BET Bromodomain Targeting by NSAIDs : Structural, Biophysical, and Computational Insights. Proteins: Structure, Function, and Bioinformatics, 94(12), 1965-1989. https://doi.org/10.1002/prot.70154
Vancouver
Sridhar A, Kandhasami N, Mathur S, Krishnappa G, Thiyagarajan S, Padmanabhan B. BET Bromodomain Targeting by NSAIDs : Structural, Biophysical, and Computational Insights. Proteins: Structure, Function, and Bioinformatics. 2026;94(12):1965-1989. doi:10.1002/prot.70154
BibTeX
@article{Sridhar2026,
author = {Sridhar, Ashok and Kandhasami, Nivetha and Mathur, Shruti and Krishnappa, Gopinatha and Thiyagarajan, Saravanamuthu and Padmanabhan, Balasundaram},
title = {BET Bromodomain Targeting by NSAIDs : Structural, Biophysical, and Computational Insights},
journal = {Proteins: Structure, Function, and Bioinformatics},
year = {2026},
volume = {94},
number = {12},
pages = {1965--1989},
doi = {10.1002/prot.70154}
}
EUVIMED